ZA975311B - Method of enhancing cognition - Google Patents

Method of enhancing cognition

Info

Publication number
ZA975311B
ZA975311B ZA975311A ZA975311A ZA975311B ZA 975311 B ZA975311 B ZA 975311B ZA 975311 A ZA975311 A ZA 975311A ZA 975311 A ZA975311 A ZA 975311A ZA 975311 B ZA975311 B ZA 975311B
Authority
ZA
South Africa
Prior art keywords
enhancing cognition
darifenacin
treatment
pharmaceutically acceptable
cognitive impairment
Prior art date
Application number
ZA975311A
Other languages
English (en)
Inventor
Michael John Allen
Brian Frank Johnson
Brian Robert Leaker
Robert Michael Wallis
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA975311B publication Critical patent/ZA975311B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01007—Acetylcholinesterase (3.1.1.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Eletrric Generators (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Soil Working Implements (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA975311A 1996-06-18 1997-06-17 Method of enhancing cognition ZA975311B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9612710.5A GB9612710D0 (en) 1996-06-18 1996-06-18 Method of treatment

Publications (1)

Publication Number Publication Date
ZA975311B true ZA975311B (en) 1998-12-17

Family

ID=10795468

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975311A ZA975311B (en) 1996-06-18 1997-06-17 Method of enhancing cognition

Country Status (15)

Country Link
US (1) US5837724A (ja)
EP (1) EP0813870B1 (ja)
JP (1) JP3453493B2 (ja)
KR (1) KR980000445A (ja)
AT (1) ATE243514T1 (ja)
AU (1) AU2495697A (ja)
CA (1) CA2208111C (ja)
DE (1) DE69722999T2 (ja)
DK (1) DK0813870T3 (ja)
ES (1) ES2197972T3 (ja)
GB (1) GB9612710D0 (ja)
HU (1) HUP9701060A3 (ja)
IL (1) IL121036A0 (ja)
PT (1) PT813870E (ja)
ZA (1) ZA975311B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040209849A1 (en) * 1998-11-27 2004-10-21 Sanochemia Pharmazeutika Aktiengesellschaft Use of effectors of the central cholinergic nervous system for treatment of delirium
GB0207104D0 (en) * 2002-03-26 2002-05-08 Pfizer Ltd Stable hydrate of a muscarinic receptor antagonist
WO2004089892A2 (en) * 2003-04-01 2004-10-21 Theravance, Inc. Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
ES2634421T3 (es) 2008-03-27 2017-09-27 Chase Pharmaceuticals Corporation Uso y composición para tratar la demencia
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
HUE044653T2 (hu) * 2009-07-22 2019-11-28 PureTech Health LLC Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk
KR102627787B1 (ko) * 2017-06-01 2024-01-23 에자이 알앤드디 매니지먼트 가부시키가이샤 피라졸로퀴놀린 유도체와 도네페질을 병용한 치매 치료제
SG11202102349PA (en) 2018-09-28 2021-04-29 Karuna Therapeutics Inc Compositions and methods for treating disorders ameliorated by muscarnic receptor activation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB9400600D0 (en) * 1994-01-14 1994-03-09 Pfizer Ltd Treatment of motion seckness

Also Published As

Publication number Publication date
HUP9701060A2 (hu) 1998-12-28
PT813870E (pt) 2003-10-31
ES2197972T3 (es) 2004-01-16
JPH1059848A (ja) 1998-03-03
HU9701060D0 (en) 1997-08-28
HUP9701060A3 (en) 1999-03-29
EP0813870B1 (en) 2003-06-25
DE69722999T2 (de) 2003-12-18
US5837724A (en) 1998-11-17
CA2208111C (en) 2002-10-15
DE69722999D1 (de) 2003-07-31
ATE243514T1 (de) 2003-07-15
DK0813870T3 (da) 2003-08-18
CA2208111A1 (en) 1997-12-18
IL121036A0 (en) 1997-11-20
EP0813870A1 (en) 1997-12-29
AU2495697A (en) 1998-01-08
KR980000445A (ko) 1998-03-30
GB9612710D0 (en) 1996-08-21
JP3453493B2 (ja) 2003-10-06

Similar Documents

Publication Publication Date Title
EP0711902A3 (en) Fracturing treatment with nitrogen and carbon dioxide in combination
SG54532A1 (en) Treated titanium dioxide
GB9309397D0 (en) Laser treatment
HK1046274A1 (en) Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders.
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
HK1022270A1 (en) Use of anti-microtubule agents for treating or preventing multiple-sclerosis
BR9711530A (pt) Combina-Æo de terapia para tratamento de psicoses
EP0619983A3 (en) Surgical needle and device for grinding it.
PH31324A (en) Method of inhibiting imperfect tissue repair.
IL128379A0 (en) Treatment of the common cold or allergic rhinitis
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
ZA979731B (en) Treatment of asthma.
ZA97986B (en) Treatment of liquors.
ZA975311B (en) Method of enhancing cognition
ZA978639B (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections.
AU1556497A (en) Agents for the treatment and prevention of aids
CA2347863A1 (en) Treatment of disorders of the outer retina
GR950100091A (en) Method for the treatment of plants.
ZA935154B (en) Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions
ZA973843B (en) Treatment of asthma with TNFR-lg.
EP0612506A3 (en) Scalpel to make controlled depth and width incisions.
EP0888780A4 (en) COMPOSITION FOR TREATING CONTACT LENSES AND METHOD FOR USE THEREOF
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
HUP0102995A3 (en) Agents and method for the protective treatment of wood
ITTO940327A0 (it) Procedimento e dispositivo per l'addolcimento elettrolitico di pezzi d'acciaio.